BridgeMD
Compares treatment options for Overactive Bladder
Official title Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder
ClinicalTrials.gov ID: NCT05798403
What this study is testing
What is Solifenacin Succinate Tablets?
Solifenacin Succinate Tablets is an investigational medicine, being studied as a potential treatment for overactive bladder.
Also referred to as Sham electroacupuncture.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Through a scientific and standardized multicenter, blinding, double-dummy, randomized controlled, noninferiority clinical trial study method, the investigators evaluated electroacupuncture as a safe and effective non-pharmacological treatment for OAB in women by comparison with Solifenacin Succinate.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75, women only
You may be able to join if
- Meet the American Urological Association (AUA) diagnostic criteria for adult overactive bladder disorder (non-neurogenic) and the Chinese Urological...
- Female patients aged 18-75 years.
- Duration of illness with OAB ≥ 3 months.
- 3≤OABSS≤11.
- No abnormality in routine urine tests.
You likely can't join if
- Combination of more serious heart, liver, kidney and other serious diseases; Or patients with severe liver or kidney insufficiency.
- Patients with pelvic organ prolapse ≥ Ⅱ degree, urinary system surgery history or pelvic floor surgery history.
- Patients with other diseases presenting with OAB symptoms.
- Those with urinary diseases (such as calculi and tuberculosis of the bladder), malignant tumors, and neurological disorders.
- Patients who are pregnant or breastfeeding.
- Patients using medication that may affect bladder function one month prior to enrollment or having received behavioural therapy for OAB three months...
See the full eligibility criteria
- Meet the American Urological Association (AUA) diagnostic criteria for adult overactive bladder disorder (non-neurogenic) and the Chinese Urological Association's Guidelines for the Diagnosis and Treatment of Urological...
- Female patients aged 18-75 years.
- Duration of illness with OAB ≥ 3 months.
- 3≤OABSS≤11.
- No abnormality in routine urine tests.
- Patients had never received acupuncture treatment.
- No mental or intellectual abnormalities, able to understand the provisions of the scales and complete the assessment.
- Consent to participate in this study and sign a written informed consent.
- Combination of more serious heart, liver, kidney and other serious diseases; Or patients with severe liver or kidney insufficiency.
- Patients with pelvic organ prolapse ≥ Ⅱ degree, urinary system surgery history or pelvic floor surgery history.
- Patients with other diseases presenting with OAB symptoms.
- Those with urinary diseases (such as calculi and tuberculosis of the bladder), malignant tumors, and neurological disorders.
- Patients who are pregnant or breastfeeding.
- Patients using medication that may affect bladder function one month prior to enrollment or having received behavioural therapy for OAB three months prior to enrolment, etc.
- Patients with pacemakers.
- Patients with blood diseases, diabetes mellitus or mental diseases.
- Infections, ulcers, abscesses, and skin infections at needling sites; metal allergy or extreme needle phobia.
- Participation in other clinical medical trial studies over the last month.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.